Affinity Asset Advisors, LLC Galectin Therapeutics Inc Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,211,400 shares of GALT stock, worth $2.8 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
1,211,400Holding current value
$2.8 Million% of portfolio
0.58%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GALT
# of Institutions
91Shares Held
9.65MCall Options Held
1.16MPut Options Held
1.98M-
Vanguard Group Inc Valley Forge, PA2.13MShares$4.93 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$3.61 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$2.73 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA863KShares$1.99 Million0.0% of portfolio
-
Commonwealth Equity Services, LLC483KShares$1.12 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $137M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...